Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.60 |
| ▸ | GLP1R | P43220 | 6/20 | 0.55 |
| ▸ | CCKBR | P32239 | 1/20 | 0.55 |
| ▸ | CALCR | P30988 | 3/20 | 0.54 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.54 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.54 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.54 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.53 |
| ▸ | ECE1 | P42892 | 1/20 | 0.52 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31098023 | 0.93 | OPRD1 (0.60) | BACE1GLP1RCCKBRECE1MUS81 | |
| SCHEMBL11564811 | 0.90 | OPRD1 (0.56) | BACE1OPRL1 | |
| SCHEMBL31038686 | 0.90 | OPRD1 (0.58) | BACE1GLP1RCCKBRECE1MUS81 | |
| SCHEMBL31098050 | 0.90 | CALCR (0.65) | GLP1RCALCRCRHR1CRHR2 | |
| SCHEMBL11589163 | 0.89 | OPRL1 (0.56) | GLP1RCRHR1CRHR2OPRL1 | |
| SCHEMBL30512625 | 0.89 | BACE1 (0.57) | BACE1OPRL1 | |
| SCHEMBL11661183 | 0.88 | OPRL1 (0.56) | BACE1GLP1RCRHR1CRHR2OPRL1 | |
| SCHEMBL31575683 | 0.88 | VIPR1 (0.61) | BACE1GLP1RCCKBRCALCRCRHR1 | |
| SCHEMBL30432126 | 0.88 | CALCR (0.68) | GLP1RCALCRCRHR1CRHR2 | |
| SCHEMBL30431778 | 0.88 | GLP1R (0.59) | BACE1GLP1RCCKBRCALCRCRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023207106-A1 | GLP-1/GIP RECEPTOR CO-AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 苏州星洲生物科技有限公司 | 2023-11-02 | — | — | WO | disclosed |